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 Candida albicans, a dimorphic fungus which is commensal organism of human gut flora, but due 
to overgrowth or immune-compromised conditions become pathogenic causing vulvovaginal 
candidiasis infection which is most common in females. The present study was conducted to 
determine an effective treatment strategy by making a comparative analysis of potency of 
azole derivatives such as itraconazole, fluconazole and ketoconazole to target ASL and GPI 
proteins responsible for pathogenesis of C. albicans using in silico approach. By comparing 
Gibbs free energy, it becomes clear that itraconazole possess more potency in comparison to 
fluconazole and ketoconazole to target ALS and GPI macromolecule. The present study clearly 
indicated that itraconazole can overcome complications of pathogenesis induced by C. albicans 
inside the host thereby acting as a major drug of interest in comparison to other azole deriva-
tives to treat vulvovaginal candidiasis.  In conclusion, itraconazole exhibits better potential 
than fluconazole and ketoconazole to target GPI and ALS. This clearly reveals the potency of 
itracaonazole to target C. albicans, but more research is needed to be carried out to determine 
the mechanistic approach involved in exhibiting this effect.  
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INTRODUCTION 
 
Pathogenesis is a biological mechanism that causes the diseased 
state. It describes the origin of adhesion, invasion, development 
and virulence of the disease (Arora et al., 2016). The vulvovagi-
nal candidiasis occurs due to the fungal infection caused by  
Candida albicans. For the study of infectious disease, microbial 
adhesion plays an important role which implies the interaction 
of the host tissue with the microorganism which is pathogenic in 
nature. In order to cause infection, microorganism has to first 
adhere to cell surface of the host organism which require some 
kind of specific protein or receptors named integrin for their 
attachment to the cell surface. In order to cause infection, micro
-organisms have to 1st adhered to the cell surfaces of the host 
cell wall which require some kind of specific proteins or recep-
tors (Pérez-Martín et al., 1999; Raperia et al., 2017). In a process 
of adhesion to the host tissue special type of proteins are  
required, these proteins are glycoproteins required by microor-
ganism or fungus in order to cause infection.  
The glycosylphosphatidylinositol (GPI) linked cell surface glyco-
proteins are the proteins which are responsible for adhesion in 
C. albicans (Kaur et al., 2016). Among all these genes, ALS3 was 
found to play an important role in adhesion as it is found to be 
upregulated during infection in case of C. albicans. Potency of 
fluconazole, Itraconazole and ketoconazole needs to be evaluat-
ed to target GPI and ALS. Furthermore, target site those  
residues which are specifically getting targeted by them also 
needs to be checked to determine the amino acid residues 
which facilitates the attachment of C. albicans to the host and 
which can be efficiently targeted by azole derivatives 
(Rustchenko-Bulgac et al., 1991). Binding potency of various 
drugs to these macromolecules needs to be evaluated. A  
comparison between their binding affinities also needs to be 
carried out to reveal that amongst these three metabolites 
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which can be proposed as a strong drug candidate for the future 
against C. albicans (Ankitha et al., 2017). Keeping in view, the 
mechanistic approach of Candida albicans causing vulvovaginitis, 
the present study was conducted, in order to identify the potent 
receptor-ligand interaction through bio-informatics approach 
so that a better understanding to the pathogenesis and hence 
the solution of the disease could be gained. 
 
MATERIALS AND METHODS 
 
Identification of proteins responsible for adhesion, invasion 
and biofilm formation of C. albicans 
In order to cause infection, micro-organisms have to 1st adhered 
to the cell surfaces of the host cell wall which require some kind 
of specific proteins or receptors. The genes responsible for  
adherence were identified from literature surveys. After the 
identification of target, their protein structure was fetched from 
RCSB protein database. Their complex structures, single chains 
were prepared by using Chimera software and were made ready 
to check their interaction with the drugs chosen for the study by 
using molecular docking approach. 
 
Preparation of 3D structures of ligands (fluconazole,  
ketoconazole and Itraconazole) 
3D structure of fluconazole, ketoconazole and Itraconazole 
were prepared by using Frog server from canonical smile  
obtained from Pubchem with Pubchem Id 3365, 456201 and 
55283, respectively.  
 
Determining the potency of fluconazole, ketoconazole and 
Itraconazole to target receptors by using molecular docking 
study 
To assess the potency of fluconazole, ketoconazole and Itracon-
azole to target ALS and GPI proteins. Virtual docking study was 
carried out at their respective catalytic domains. 3D structure 
of ALS and GPI were obtained from RCSB protein database. 
Ligands were docked to the receptor chosen for the study by 
using Autodock tool of Autodock 4.2.6 package. Grid map of 
40×40×40 grid point with 0.375 Å spacing were generated  
using Autogrid program. According to Lamarckian Genetic  
Algorithm (LGA) with maximum 250000 energy, binding  
efficiency of ligands to various receptors was determined (Trott 
and Olson, 2010; Mittal et al., 2018; Ferreira et al., 2015 and 
Morris et al., 2009). 
 
RESULTS AND DISCUSSION 
 
Identification of proteins responsible for adhesion, invasion 
and biofilm formation of C. albicans 
Akhtar et al. (2012) in their clinical trial study mentioned that  
itraconazole is more effective for the treatment of vulvovaginal 
candidiasis in comparison to fluconazole but they couldn’t explain 
the mechanistic approach exhibited by itraconazole in exhibiting 
this effect (Akhtar et al., 2012). In this phase of study we identified 
that glycosylphosphatidylinositol (GPI) linked cell surface glyco-
proteins are the proteins which are responsible for adhesion in C. 
albicans, they are encoded by 8 sets of Agglutinin like sequences 
genes (ALS) which are: ALS1, ALS2, ALS3, ALS4, ALS5, ALS6, ALS7 
and ALS9. Among all these genes, ALS3 was found to play an  
important role in adhesion as it is found to be upregulated during 
infection in case of C. albicans. ALS3 is most commonly seen in oral 
and vaginal epithelial cell infection. In order to provide a perma-
nent cure from the disease, adhesion of C. albicans to the host 
needs to be controlled. Potency of fluconazole, Itraconazole and 
ketoconazole needs to be evaluated to target GPI and ALS. To 
carry out in silico study different chains using Chimera software 
were prepared: ALS complex (Figure 1A), Chain A (Figure 1B), 
Chain B (Figure 1C), Chain C (Figure 1D) and Chain D (Figure 1E) 
and GPI complex (Figure 2A), Chain A (Figure 2B), Chain B (Figure 
2C), Chain C (Figure 2D) and Chain D (Figure 2E). 
Figure 1. 3-D complex structure of ALS protein (A), chain A (B), chain B (C), 
chain C (D) and chain D (E). 
Figure 2. 3-D complex structure of GPI protein (A), chain A (B), chain B (C), 
chain C (D) and chain D (E).  
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Preparation of 3D structures of ligands (fluconazole, ketocona-
zole and Itraconazole) 
Canonical smiles were fetched from PubChem. 3D structures of 
ligands were prepared by using canonical smiles from FROG 
server. 3D structures were downloaded. Single isomeric struc-
tures were prepared from complex structures by using Chimera. 
Chemistry of ligands was studied, to check location of different 
atoms. Structures of fluconazole (Figure 3A), fluconazole isomer 
(Figure 3B), Itraconazole (Figure 3C), Itraconazole isomer 
(Figure 3D), ketoconazole (Figure 3E) and ketoconazole isomer 
(Figure 3F) were prepared by using Chimera software.  
 
Determination of the potency of fluconazole, ketoconazole 
and Itraconazole to target receptors by using molecular dock-
ing study 
In order to assess the potential of various azole derivatives 
namely fluconazole, Itraconazole and ketoconazole; molecular 
docking study was carried out at the catalytic domain of ALS and 
GPI proteins.  Fluconazole, Itraconazole and ketoconazole were 
docked with the respective chain of ALS and GPI and it was 
found that Itraconazole exhibits highest potential to target ALS 
and GPI. Binding with all the chains respectively exhibits equiva-
lent binding affinity to and same affinity of fluconazole, Itracon-
azole and ketoconazole to target all the chains with equal poten-
tial. When a comparison was made among the different chains of 
ALs and GPI, it was observed that all these three chemical  
moieties are targeting these receptors with equal potency.  
Itracaonazole was found to exhibit highest potency to target 
ALS and GPI, binding affinity was found to be higher than  
ketoconazole and fluconazole.  
 
Assessment of potency of fluconazole, Itraconazole and  
ketoconazole to target ALS  
Molecular docking study was carried out to determine potency 
of fluconazole, Itraconazole and ketoconazole to target ALS. It 
was observed that ALS macromolecule forms the binding site 
with fluconazole comprises of SER124, THR122, PHE183, 
VAL184 residues and displays binding affinity of – 5.0 Kcal/mol 
(Figure 4A) on the other hand when binding affinity of Itracona-
zole with ALs macromolecule was assessed it was observed that 
Itraconazole exhibits binding affinity of – 7.1 Kcal/mol at site 
comprises of THR62, PHE60, SER124, GLY123 residues (Figure 
4B). When binding affinity of ketoconazole with ALS macromol-
ecule was assessed it was observed that ketoconazole exhibits 
binding affinity of - 6.0 Kcal/mol at site comprises of SER124, 
MET59, PHE60, GLY304 residues (Figure 4C). By comparing 
Gibbs free energy of binding of all three molecules, it becomes 
clear that Itraconazole possess more potency in comparison to 
fluconazole and ketoconazole to target ALS macromolecule. 
Chain A, B, C and D were docked separately with fluconazole, 
Itraconazole and ketoconazole but the binding affinity as  
revealed from Gibbs free energy level shows that all three  
compounds exhibited equivalent binding affinity at different 
chains but with different binding sites.  
Figure 3. Fluconazole (A), fluconazole isomer (B), itraconazole (C),  
itraconazole isomer (D), ketoconazole (E) and ketoconazole isomer (F). 




Assessment of potency of fluconazole, Itraconazole and  
ketoconazole to target GPIs 
In a process of adhesion to the host tissue special type of  
proteins are required, these proteins are glycoproteins required 
by microorganism in order to cause infection. The glyco-
sylphosphatidylinositol (GPI) linked cell surface glycoproteins 
are the proteins which are responsible for adhesion of  
C. albicans to the host which further plays a prominent role in 
enhancing complexity of the disease. In order to evaluate poten-
cy of fluconazole, Itraconazole and ketoconazole to target GPI 
virtual docking study was carried out individually at all the 4 
different chains of GPI. It was observed that GPI macromolecule 
forms the binding site with fluconazole comprises of VAL115, 
ASP158, VAL162, ILE275 residues and displays binding affinity 
of – 5.3 Kcal/mol (Figure 5A) on the other hand when binding 
affinity of Itraconazole with GPI macromolecule was assessed it 
was observed that Itraconazole exhibits binding affinity of – 7.5 
Kcal/mol at site comprises of GLN349, LEU487, VAL162, 
ALA189 residues (Figure 5B). When binding affinity of ketocon-
azole with GPI macromolecule was assessed it was observed 
that ketoconazole exhibits binding affinity of -6.5 Kcal/mol at 
site comprises of GLU353, LYS548, ALA496, LYS357 residues 
(Figure 5C). By comparing Gibbs free energy of binding of all 
three molecules, it becomes clear that Itraconazole possess 
more potency in comparison to fluconazole and ketoconazole to 
target ALS macromolecule. Chain A, B, C and D were docked 
separately with fluconazole, Itraconazole and ketoconazole but 
the binding affinity as revealed from Gibbs free energy level 
shows that all three compounds exhibited equivalent binding 
affinity at different chains but with different binding sites and 
amongst all the three different moieties Itraconazole exhibits 
better potential than fluconazole and ketoconazole to target 
GPI (Spacek and Buchta, 2005). This clearly reveals that more 
research needs to be carried out on Itracaonazole to further 




Vulvovaginal candidiasis has become a major havoc as currently 
70-80% of women are affected from it. Overgrowth of  
C. albicans is considered to be a major causative agent of disease. 
Azole derivatives are considered to be potential drug of interest 
against it but the infection rate is increasing rapidly. Lack of 
identification of molecular pathways involved in complicating 
the disease further reduces the chances of providing an  
effective treatment strategy. The present study has identified 
the molecular target involved in enhancing the disease by  
inducing pathogenesis along with an effective therapeutic  
approach against it. Itraconazole can efficiently target GPIs and 
ALS which predominantly contributes to event of pathogenesis 
even better than fluconazole and ketoconazole. Researchers 
need to focus more on the molecular targets and the best suited 
approach to fight against the disease.  
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Figure 5. Docked structure of GPIs with fluconazole (A), itraconazole (B) 
and ketoconazole (C). 
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